Listed

ProtoKinetix, Inc.

PKTXOTCCIK 1128189HealthcareFiscal year ends Dec 31

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Net income−$120.0k, Q4 FY2025
ProtoKinetix, Inc., income statement, quarterly
Line itemUnitQ1 FY20232023-03-31Q2 FY20232023-06-30Q3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31
Revenue$knot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Research and development$k22.7Research and development, Q1 FY2023, three months to 2023-03-31$22.7k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2024-05-15, accession 0001079973-24-000714.Report this figure32.0Research and development, Q2 FY2023, three months to 2023-06-30$32.0k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2024-07-30, accession 0001079973-24-001123.Report this figure21.3Research and development, Q3 FY2023, three months to 2023-09-30$21.3k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2024-11-12, accession 0001079973-24-001493.Report this figure36.5Research and development, Q4 FY2023, three months to 2023-12-31$36.5k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2025-03-28, accession 0001079973-25-000516. Derived: 12-month figure less the 9-month figure.Report this figure36.6Research and development, Q1 FY2024, three months to 2024-03-31$36.6k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-05-15, accession 0001079973-25-000816.Report this figure21.0Research and development, Q2 FY2024, three months to 2024-06-30$21.0k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-08-13, accession 0001079973-25-001254.Report this figure21.0Research and development, Q3 FY2024, three months to 2024-09-30$21.0k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-13, accession 0001079973-25-001708.Report this figure21.0Research and development, Q4 FY2024, three months to 2024-12-31$21.0k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-09-03, accession 0001079973-26-001218. Derived: 12-month figure less the 9-month figure.Report this figure33.8Research and development, Q1 FY2025, three months to 2025-03-31$33.8k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-05-15, accession 0001079973-25-000816.Report this figure24.4Research and development, Q2 FY2025, three months to 2025-06-30$24.4k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-08-13, accession 0001079973-25-001254.Report this figure24.2Research and development, Q3 FY2025, three months to 2025-09-30$24.2k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-13, accession 0001079973-25-001708.Report this figure24.2Research and development, Q4 FY2025, three months to 2025-12-31$24.2k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-09-03, accession 0001079973-26-001218. Derived: 12-month figure less the 9-month figure.Report this figure
Operating income$knot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Interest expense$knot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Net income$k(107)Net income, Q1 FY2023, three months to 2023-03-31−$107.0k. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2024-05-15, accession 0001079973-24-000714.Report this figure(116)Net income, Q2 FY2023, three months to 2023-06-30−$115.6k. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2024-07-30, accession 0001079973-24-001123.Report this figure(80.4)Net income, Q3 FY2023, three months to 2023-09-30−$80.4k. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2024-11-12, accession 0001079973-24-001493.Report this figure(112)Net income, Q4 FY2023, three months to 2023-12-31−$112.5k. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2025-03-28, accession 0001079973-25-000516. Derived: 12-month figure less the 9-month figure.Report this figure(92.0)Net income, Q1 FY2024, three months to 2024-03-31−$92.0k. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-05-15, accession 0001079973-25-000816.Report this figure(85.1)Net income, Q2 FY2024, three months to 2024-06-30−$85.1k. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-08-13, accession 0001079973-25-001254.Report this figure(84.6)Net income, Q3 FY2024, three months to 2024-09-30−$84.6k. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-13, accession 0001079973-25-001708.Report this figure(103)Net income, Q4 FY2024, three months to 2024-12-31−$102.5k. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-09-03, accession 0001079973-26-001218. Derived: 12-month figure less the 9-month figure.Report this figure(97.7)Net income, Q1 FY2025, three months to 2025-03-31−$97.7k. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-05-15, accession 0001079973-25-000816.Report this figure(91.1)Net income, Q2 FY2025, three months to 2025-06-30−$91.1k. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-08-13, accession 0001079973-25-001254.Report this figure(84.9)Net income, Q3 FY2025, three months to 2025-09-30−$84.9k. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-13, accession 0001079973-25-001708.Report this figure(120)Net income, Q4 FY2025, three months to 2025-12-31−$120.0k. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-09-03, accession 0001079973-26-001218. Derived: 12-month figure less the 9-month figure.Report this figure
Diluted EPS$ per share(0.01)Diluted EPS, Q1 FY2023, three months to 2023-03-31−$0.01 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2024-05-15, accession 0001079973-24-000714.Report this figure(0.01)Diluted EPS, Q2 FY2023, three months to 2023-06-30−$0.01 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2024-07-30, accession 0001079973-24-001123.Report this figure(0.01)Diluted EPS, Q3 FY2023, three months to 2023-09-30−$0.01 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2024-11-12, accession 0001079973-24-001493.Report this figurenot reported0.00Diluted EPS, Q1 FY2024, three months to 2024-03-31$0.00 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-05-15, accession 0001079973-25-000816.Report this figure0.00Diluted EPS, Q2 FY2024, three months to 2024-06-30$0.00 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-08-13, accession 0001079973-25-001254.Report this figure0.00Diluted EPS, Q3 FY2024, three months to 2024-09-30$0.00 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-13, accession 0001079973-25-001708.Report this figurenot reported0.00Diluted EPS, Q1 FY2025, three months to 2025-03-31$0.00 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-05-15, accession 0001079973-25-000816.Report this figure0.00Diluted EPS, Q2 FY2025, three months to 2025-06-30$0.00 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-08-13, accession 0001079973-25-001254.Report this figure0.00Diluted EPS, Q3 FY2025, three months to 2025-09-30$0.00 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-13, accession 0001079973-25-001708.Report this figurenot reported
Basic EPS$ per share(0.01)Basic EPS, Q1 FY2023, three months to 2023-03-31−$0.01 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2024-05-15, accession 0001079973-24-000714.Report this figure(0.01)Basic EPS, Q2 FY2023, three months to 2023-06-30−$0.01 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2024-07-30, accession 0001079973-24-001123.Report this figure(0.01)Basic EPS, Q3 FY2023, three months to 2023-09-30−$0.01 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2024-11-12, accession 0001079973-24-001493.Report this figurenot reported0.00Basic EPS, Q1 FY2024, three months to 2024-03-31$0.00 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-05-15, accession 0001079973-25-000816.Report this figure0.00Basic EPS, Q2 FY2024, three months to 2024-06-30$0.00 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-08-13, accession 0001079973-25-001254.Report this figure0.00Basic EPS, Q3 FY2024, three months to 2024-09-30$0.00 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-13, accession 0001079973-25-001708.Report this figurenot reported0.00Basic EPS, Q1 FY2025, three months to 2025-03-31$0.00 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-05-15, accession 0001079973-25-000816.Report this figure0.00Basic EPS, Q2 FY2025, three months to 2025-06-30$0.00 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-08-13, accession 0001079973-25-001254.Report this figure0.00Basic EPS, Q3 FY2025, three months to 2025-09-30$0.00 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-13, accession 0001079973-25-001708.Report this figurenot reported

Balance sheet

Shareholders' equity$297.9k, FY2025
ProtoKinetix, Inc., balance sheet, quarterly
Line itemUnitQ1 FY20232023-03-31Q2 FY20232023-06-30Q3 FY20232023-09-30FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30FY20252025-12-31
Cash and equivalents$knot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Current assets$k8.0Current assets, Q1 FY2023, at 2023-03-31$8.0k. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2023-05-02, accession 0001079973-23-000595.Report this figure19.7Current assets, Q2 FY2023, at 2023-06-30$19.7k. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2023-07-14, accession 0001079973-23-000958.Report this figure13.4Current assets, Q3 FY2023, at 2023-09-30$13.4k. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2023-10-18, accession 0001079973-23-001455.Report this figure21.5Current assets, FY2023, at 2023-12-31$21.5k. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-11-12, accession 0001079973-24-001493.Report this figure3.9Current assets, Q1 FY2024, at 2024-03-31$3.9k. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-05-15, accession 0001079973-24-000714.Report this figure3.3Current assets, Q2 FY2024, at 2024-06-30$3.3k. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-07-30, accession 0001079973-24-001123.Report this figure6.7Current assets, Q3 FY2024, at 2024-09-30$6.7k. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-11-12, accession 0001079973-24-001493.Report this figurenot reportednot reportednot reportednot reportednot reported
Total assets$k447Total assets, Q1 FY2023, at 2023-03-31$447.3k. XBRL concept us-gaap:Assets. 10-Q filed 2023-05-02, accession 0001079973-23-000595.Report this figure467Total assets, Q2 FY2023, at 2023-06-30$467.0k. XBRL concept us-gaap:Assets. 10-Q filed 2023-07-14, accession 0001079973-23-000958.Report this figure451Total assets, Q3 FY2023, at 2023-09-30$450.9k. XBRL concept us-gaap:Assets. 10-Q filed 2023-10-18, accession 0001079973-23-001455.Report this figure481Total assets, FY2023, at 2023-12-31$480.6k. XBRL concept us-gaap:Assets. 10-K filed 2025-03-28, accession 0001079973-25-000516.Report this figure461Total assets, Q1 FY2024, at 2024-03-31$461.4k. XBRL concept us-gaap:Assets. 10-Q filed 2024-05-15, accession 0001079973-24-000714.Report this figure474Total assets, Q2 FY2024, at 2024-06-30$473.5k. XBRL concept us-gaap:Assets. 10-Q filed 2024-07-30, accession 0001079973-24-001123.Report this figure479Total assets, Q3 FY2024, at 2024-09-30$479.3k. XBRL concept us-gaap:Assets. 10-Q filed 2024-11-12, accession 0001079973-24-001493.Report this figure466Total assets, FY2024, at 2024-12-31$466.1k. XBRL concept us-gaap:Assets. 10-K filed 2026-09-03, accession 0001079973-26-001218.Report this figure529Total assets, Q1 FY2025, at 2025-03-31$528.6k. XBRL concept us-gaap:Assets. 10-Q filed 2025-05-15, accession 0001079973-25-000816.Report this figure474Total assets, Q2 FY2025, at 2025-06-30$474.4k. XBRL concept us-gaap:Assets. 10-Q filed 2025-08-13, accession 0001079973-25-001254.Report this figure478Total assets, Q3 FY2025, at 2025-09-30$477.6k. XBRL concept us-gaap:Assets. 10-Q filed 2025-11-13, accession 0001079973-25-001708.Report this figure483Total assets, FY2025, at 2025-12-31$483.4k. XBRL concept us-gaap:Assets. 10-K filed 2026-09-03, accession 0001079973-26-001218.Report this figure
Current liabilities$k53.0Current liabilities, Q1 FY2023, at 2023-03-31$53.0k. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2023-05-02, accession 0001079973-23-000595.Report this figure13.3Current liabilities, Q2 FY2023, at 2023-06-30$13.3k. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2023-07-14, accession 0001079973-23-000958.Report this figure12.6Current liabilities, Q3 FY2023, at 2023-09-30$12.6k. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2023-10-18, accession 0001079973-23-001455.Report this figure44.7Current liabilities, FY2023, at 2023-12-31$44.7k. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2025-03-28, accession 0001079973-25-000516.Report this figure67.6Current liabilities, Q1 FY2024, at 2024-03-31$67.6k. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-05-15, accession 0001079973-24-000714.Report this figure58.8Current liabilities, Q2 FY2024, at 2024-06-30$58.8k. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-07-30, accession 0001079973-24-001123.Report this figure87.7Current liabilities, Q3 FY2024, at 2024-09-30$87.7k. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-11-12, accession 0001079973-24-001493.Report this figure124Current liabilities, FY2024, at 2024-12-31$124.0k. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-09-03, accession 0001079973-26-001218.Report this figure152Current liabilities, Q1 FY2025, at 2025-03-31$152.2k. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-05-15, accession 0001079973-25-000816.Report this figure149Current liabilities, Q2 FY2025, at 2025-06-30$149.1k. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-08-13, accession 0001079973-25-001254.Report this figure227Current liabilities, Q3 FY2025, at 2025-09-30$227.2k. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-11-13, accession 0001079973-25-001708.Report this figure185Current liabilities, FY2025, at 2025-12-31$185.4k. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-09-03, accession 0001079973-26-001218.Report this figure
Total liabilities$knot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Short-term borrowings$knot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Shareholders' equity$k394Shareholders' equity, Q1 FY2023, at 2023-03-31$394.3k. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-07-30, accession 0001079973-24-001123.Report this figure454Shareholders' equity, Q2 FY2023, at 2023-06-30$453.7k. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-11-12, accession 0001079973-24-001493.Report this figure438Shareholders' equity, Q3 FY2023, at 2023-09-30$438.3k. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-11-12, accession 0001079973-24-001493.Report this figure436Shareholders' equity, FY2023, at 2023-12-31$435.9k. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-09-03, accession 0001079973-26-001218.Report this figure394Shareholders' equity, Q1 FY2024, at 2024-03-31$393.8k. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-08-13, accession 0001079973-25-001254.Report this figure415Shareholders' equity, Q2 FY2024, at 2024-06-30$414.8k. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-13, accession 0001079973-25-001708.Report this figure392Shareholders' equity, Q3 FY2024, at 2024-09-30$391.5k. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-13, accession 0001079973-25-001708.Report this figure342Shareholders' equity, FY2024, at 2024-12-31$342.1k. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-09-03, accession 0001079973-26-001218.Report this figure376Shareholders' equity, Q1 FY2025, at 2025-03-31$376.4k. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-08-13, accession 0001079973-25-001254.Report this figure325Shareholders' equity, Q2 FY2025, at 2025-06-30$325.3k. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-13, accession 0001079973-25-001708.Report this figure250Shareholders' equity, Q3 FY2025, at 2025-09-30$250.4k. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-13, accession 0001079973-25-001708.Report this figure298Shareholders' equity, FY2025, at 2025-12-31$297.9k. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-09-03, accession 0001079973-26-001218.Report this figure

Cash flow

Operating cash flow$558, Q4 FY2025
ProtoKinetix, Inc., cash flow, quarterly
Line itemUnitQ1 FY20232023-03-31Q2 FY20232023-06-30Q3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31
Operating cash flow$k(84.9)Operating cash flow, Q1 FY2023, three months to 2023-03-31−$84.9k. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2024-05-15, accession 0001079973-24-000714.Report this figure(144)Operating cash flow, Q2 FY2023, three months to 2023-06-30−$143.8k. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2024-07-30, accession 0001079973-24-001123. Derived: 6-month figure less the 3-month figure.Report this figure(69.9)Operating cash flow, Q3 FY2023, three months to 2023-09-30−$69.9k. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2024-11-12, accession 0001079973-24-001493. Derived: 9-month figure less the 6-month figure.Report this figure(77.5)Operating cash flow, Q4 FY2023, three months to 2023-12-31−$77.5k. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2025-03-28, accession 0001079973-25-000516. Derived: 12-month figure less the 9-month figure.Report this figure(57.8)Operating cash flow, Q1 FY2024, three months to 2024-03-31−$57.8k. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-05-15, accession 0001079973-25-000816.Report this figure(80.9)Operating cash flow, Q2 FY2024, three months to 2024-06-30−$80.9k. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-08-13, accession 0001079973-25-001254. Derived: 6-month figure less the 3-month figure.Report this figure(39.1)Operating cash flow, Q3 FY2024, three months to 2024-09-30−$39.1k. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-13, accession 0001079973-25-001708. Derived: 9-month figure less the 6-month figure.Report this figure(45.2)Operating cash flow, Q4 FY2024, three months to 2024-12-31−$45.2k. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-09-03, accession 0001079973-26-001218. Derived: 12-month figure less the 9-month figure.Report this figure(52.0)Operating cash flow, Q1 FY2025, three months to 2025-03-31−$52.0k. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-05-15, accession 0001079973-25-000816.Report this figure(80.1)Operating cash flow, Q2 FY2025, three months to 2025-06-30−$80.1k. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-08-13, accession 0001079973-25-001254. Derived: 6-month figure less the 3-month figure.Report this figure(3.9)Operating cash flow, Q3 FY2025, three months to 2025-09-30−$3.9k. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-13, accession 0001079973-25-001708. Derived: 9-month figure less the 6-month figure.Report this figure0.6Operating cash flow, Q4 FY2025, three months to 2025-12-31$558. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-09-03, accession 0001079973-26-001218. Derived: 12-month figure less the 9-month figure.Report this figure

Shares

Diluted shares (weighted)389.45m, Q3 FY2025
ProtoKinetix, Inc., shares, quarterly
Line itemUnitQ3 FY20212021-09-30Q2 FY20222022-06-30Q3 FY20222022-09-30Q1 FY20232023-03-31Q2 FY20232023-06-30Q3 FY20232023-09-30Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30
Diluted shares (weighted)m shares293Diluted shares (weighted), Q3 FY2021, three months to 2021-09-30293,201,373 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2021-11-12, accession 0001079973-21-001122.Report this figure291Diluted shares (weighted), Q2 FY2022, three months to 2022-06-30290,989,603 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2023-07-14, accession 0001079973-23-000958.Report this figure291Diluted shares (weighted), Q3 FY2022, three months to 2022-09-30290,989,603 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2023-10-18, accession 0001079973-23-001455.Report this figure325Diluted shares (weighted), Q1 FY2023, three months to 2023-03-31325,457,929 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-05-15, accession 0001079973-24-000714.Report this figure336Diluted shares (weighted), Q2 FY2023, three months to 2023-06-30335,630,151 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-07-30, accession 0001079973-24-001123.Report this figure336Diluted shares (weighted), Q3 FY2023, three months to 2023-09-30335,630,151 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-11-12, accession 0001079973-24-001493.Report this figure333Diluted shares (weighted), Q1 FY2024, three months to 2024-03-31333,102,754 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-05-15, accession 0001079973-25-000816.Report this figure354Diluted shares (weighted), Q2 FY2024, three months to 2024-06-30353,972,460 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-08-13, accession 0001079973-25-001254.Report this figure365Diluted shares (weighted), Q3 FY2024, three months to 2024-09-30364,849,717 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-13, accession 0001079973-25-001708.Report this figure374Diluted shares (weighted), Q1 FY2025, three months to 2025-03-31374,148,485 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-05-15, accession 0001079973-25-000816.Report this figure354Diluted shares (weighted), Q2 FY2025, three months to 2025-06-30353,972,460 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-08-13, accession 0001079973-25-001254.Report this figure389Diluted shares (weighted), Q3 FY2025, three months to 2025-09-30389,449,717 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-13, accession 0001079973-25-001708.Report this figure

Shares outstanding: 411.63mShares outstanding, period not labelled, at 2026-09-02411,630,152 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-K filed 2026-09-03, accession 0001079973-26-001218.Report this figure at Sep 2, 2026, from the cover of the 10-K filed Sep 3, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:34 ET. Listed shows no prices and gives no investment advice.